OpenVSafe by OpenVAERS
Search V-safe

8PK-27647-10138

4 vaccinations 11 coded responses 46 check-ins 12 free-text entries 7 call cases
Sex
Female
Age at first dose
56-60
ZIP prefix
220 / VA
Registered
2021-04-10
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Possible VAERS report

VAERS IDConfidenceScoreRunner-upShared symptomsDose StateVAERS vaccinated / onset / receivedCall case
2130066 (opens in a new window) high 10 / 11 2 2 of 8 VAERS symptoms same dose (2) VA matches 2021-04-30 / 2021-05-02 / 2022-02-21
received the same day as the last call
case 627935

From the VAERS matching of call center cases (loader/vaers_match_*). Only the best match is shown, and only if it scores 8 or more out of 11. The score adds up timing (VAERS received soon after the call center contact), dose and shared symptoms; state only breaks ties. Confidence is high when the score is 8+ and at least 3 points ahead of the runner-up, medium when 5+ and 2 ahead, otherwise low. A match is a likely link, not a confirmed one.

Timeline

  1. 2021-04-09
    Dose 1 — Pfizer-BioNTech
  2. 2021-04-10
    Registered in v-safe
  3. 2021-04-10
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  4. 2021-04-11
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2021-04-12
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-04-13
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-04-14
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-04-15
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-04-16
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-04-23
    Survey response — day 14, dose 1
    MedDRA: Pre-existing disease, Vertigo — Feeling: Good · Be unable to work
    Free text: Independent of receiving a vaccine, I have a history of experiencing symptoms of vertigo since 2014, which tends to increase in the Spring with the pollen count. Which can result in missing a day of work. Such was the scenario this week.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-04-30
    Dose 2 — Pfizer-BioNTech
  12. 2021-04-30
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  13. 2021-05-01
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  14. 2021-05-02
    Survey response — days 1–6 daily, dose 2
    MedDRA: Abdominal discomfort, Abdominal pain, Chest discomfort, Emergency care, Musculoskeletal chest pain, Unevaluable event — Feeling: Poor · Site: Pain · Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit
    Free text: Systemic reaction (other): Pressurized discomfort pain throughout abdominal and rib cage with chest tightness requiring ER care and testing · Healthcare visit (other): In the midst of cardiac and abdominal work-up at (b)(6)
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-05-02
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  16. 2021-05-03
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to work
    Adult check-in
  17. 2021-05-04
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Fatigue or tiredness, Abdominal pain · Be unable to work or attend school
    Adult check-in
  18. 2021-05-05
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Fatigue or tiredness
    Adult check-in
  19. 2021-05-06
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  20. 2021-05-07
    Health check-in — day 7, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  21. 2021-05-14
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-05-21
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-05-28
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-06-11
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-07-30
    Survey response — 3 months, dose 2
    MedDRA: Drug therapeutic incompatibility — Feeling: Fair · Be unable to work or attend school
    Free text: Increase sensitivity to anti-vertigo medications (meclizine).
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  26. 2021-10-29
    Survey response — 6 months, dose 2
    MedDRA: Dyspnoea, Vertigo — Feeling: Fair · Be unable to work or attend school
    Free text: Episodes of shortness of breath. Increase sensitivity to vertigo medications (e.g., extended sedation).
    MedDRA releases: 2024-11 · check-in free text available
  27. 2022-01-10
  28. 2022-01-21
    Dose 3 — Pfizer-BioNTech
  29. 2022-01-22
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain · Fatigue or tiredness
    Adult check-in
  30. 2022-01-23
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  31. 2022-01-24
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain · Chills, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activities
    Adult check-in
  32. 2022-01-25
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain · Fatigue or tiredness, Diarrhea
    Adult check-in
  33. 2022-01-26
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Fatigue or tiredness
    Adult check-in
  34. 2022-01-27
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  35. 2022-01-29
    Health check-in — day 7, dose 3
    Feeling: Fair · Fatigue or tiredness
    Adult check-in
  36. 2022-02-04
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  37. 2022-02-11
    Survey response — day 21, dose 3
    MedDRA: Heart rate increased, Unevaluable event — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Symptoms: Extremely high and frequent heart rate. · Healthcare visit (other): Lab Work and medications ordered and cardiac specialty consult with an electrophysiologist being coordinated.
    MedDRA releases: 2024-11 · check-in free text available
  38. 2022-02-11
    Report sent to call center — day 21, dose 3
    Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  39. 2022-02-17
  40. 2022-02-20
    Survey response — day 28, dose 3
    MedDRA: Tachycardia, Unevaluable event — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Symptoms: Continued tachycardia. Adjusting to a newly ordered cardiac medication which has been sedating. · Healthcare visit (other): Cardiac medication and lab work ordered follow-up appointment with electrophysiologist scheduled.
    MedDRA releases: 2024-11 · check-in free text available
  41. 2022-02-20
    Report sent to call center — day 28, dose 3
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  42. 2022-02-21
  43. 2022-02-21
    Call successful
    Completed over the phone
  44. 2022-02-25
    Survey response — day 35, dose 3
    MedDRA: Arrhythmia, Tachycardia — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: In the midst of cardiac monitoring for tachycardia and arrhythmias.
    MedDRA releases: 2024-11 · check-in free text available
  45. 2022-02-25
    Report sent to call center — day 35, dose 3
    Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  46. 2022-03-02
  47. 2022-03-05
    Survey response — day 42, dose 3
    MedDRA: Arrhythmia, Medical counselling, Tachycardia — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: I am under medical care for arrhythmias and tachycardia.
    MedDRA releases: 2024-11 · check-in free text available
  48. 2022-03-05
    Report sent to call center — day 42, dose 3
    Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
  49. 2022-03-08
  50. 2022-07-22
    Survey response — 6 months, dose 3
    MedDRA: Arrhythmia, Gallbladder operation — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Hospitalization
    Free text: Symptoms: Cardiac arrhythmias and gallbladder surgery. · Healthcare visit (other): Gallbladder Surgery
    MedDRA releases: 2024-11 · check-in free text available
  51. 2022-07-22
    Report sent to call center — 6 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · Hospitalization · 1 call case(s)
  52. 2022-07-25
  53. 2022-07-28
  54. 2022-09-20
    Call successful
    Participant prefers to complete VAERS report online
  55. 2022-09-20
    Call successful
    Participant prefers to complete VAERS report online
  56. 2022-09-20
    Call successful
    Participant prefers to complete VAERS report online
  57. 2022-09-20
    Call successful
    Participant prefers to complete VAERS report online
  58. 2022-09-20
    Call successful
    Participant prefers to complete VAERS report online
  59. 2022-09-24
    Dose 4 — Pfizer-BioNTech
  60. 2022-09-24
    Health check-in — day 0, dose 4
    Feeling: Fair · Site: Pain · Fatigue or tiredness
    Adult check-in
  61. 2022-09-26
    Survey response — days 1–6 daily, dose 4
    MedDRA: Feeling hot — Feeling: Fair · Site: Pain · Fatigue or tiredness
    Free text: Hot/Warm Spells
    MedDRA releases: 2024-11 · check-in free text available
  62. 2022-09-29
    Survey response — days 1–6 daily, dose 4
    MedDRA: Hot flush — Feeling: Fair · Fatigue or tiredness
    Free text: Hot Flashes
    MedDRA releases: 2024-11 · check-in free text available
  63. 2022-09-30
    Health check-in — days 1–6 daily, dose 4
    Feeling: Fair · Fatigue or tiredness
    Adult check-in
  64. 2022-10-01
    Health check-in — day 7, dose 4
    Feeling: Fair · Chills, Fatigue or tiredness
    Adult check-in
  65. 2022-10-10
    Health check-in — day 14, dose 4
    Feeling: Fair
    Adult check-in
  66. 2022-10-15
    Health check-in — day 21, dose 4
    Feeling: Fair
    Adult check-in
  67. 2022-10-24
    Health check-in — day 28, dose 4
    Feeling: Fair
    Adult check-in
  68. 2022-10-29
    Health check-in — day 35, dose 4
    Feeling: Fair
    Adult check-in
  69. 2022-11-05
    Health check-in — day 42, dose 4
    Feeling: Fair
    Adult check-in
  70. 2022-12-24
    Health check-in — 3 months, dose 4
    Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: A severe upper respiratory infection, which after 1.5 weeks required treatment with an antibiotic (Amoxicillin).
    Adult check-in · check-in free text available
  71. 2022-12-24
  72. 2022-12-28
    Call successful
    Completed over the phone

Vaccinations

DoseDateManufacturerCo-administered
12021-04-09Pfizer-BioNTech
22021-04-30Pfizer-BioNTech
32022-01-21Pfizer-BioNTech No
42022-09-24Pfizer-BioNTech No

Call center

7 call center cases

7 successful

VAERS report filed, before or during a call: 2

1 wait over 3 months for a first call

See the call center timeline

Free text

Release 7 — day 14, dose 1

2021-04-23

Symptoms: Independent of receiving a vaccine, I have a history of experiencing symptoms of vertigo since 2014, which tends to increase in the Spring with the pollen count. Which can result in missing a day of work. Such was the scenario this week.

Release 8 — days 1–6 daily, dose 2

2021-05-02

Systemic reaction (other): Pressurized discomfort pain throughout abdominal and rib cage with chest tightness requiring ER care and testing
Healthcare visit (other): In the midst of cardiac and abdominal work-up at (b)(6)
redacted (b)(6)

Release 9 — 3 months, dose 2

2021-07-30

Symptoms: Increase sensitivity to anti-vertigo medications (meclizine).

Release 10 — 6 months, dose 2

2021-10-29

Symptoms: Episodes of shortness of breath. Increase sensitivity to vertigo medications (e.g., extended sedation).

Release 11 — day 21, dose 3

2022-02-11

Symptoms: Extremely high and frequent heart rate.
Healthcare visit (other): Lab Work and medications ordered and cardiac specialty consult with an electrophysiologist being coordinated.

Release 11 — day 28, dose 3

2022-02-20

Symptoms: Continued tachycardia. Adjusting to a newly ordered cardiac medication which has been sedating.
Healthcare visit (other): Cardiac medication and lab work ordered follow-up appointment with electrophysiologist scheduled.

Release 11 — day 35, dose 3

2022-02-25

Symptoms: In the midst of cardiac monitoring for tachycardia and arrhythmias.

Release 11 — day 42, dose 3

2022-03-05

Symptoms: I am under medical care for arrhythmias and tachycardia.

Release 12 — 6 months, dose 3

2022-07-22

Symptoms: Cardiac arrhythmias and gallbladder surgery.
Healthcare visit (other): Gallbladder Surgery

Release 12 — days 1–6 daily, dose 4

2022-09-26

Systemic reaction (other): Hot/Warm Spells

2022-09-29

Systemic reaction (other): Hot Flashes

Release 12 — 3 months, dose 4

2022-12-24

Symptoms: A severe upper respiratory infection, which after 1.5 weeks required treatment with an antibiotic (Amoxicillin).

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOGallbladder operation · · ✓
HCVOUnevaluable event ✓ ✓ ✓
SDArrhythmia · · ✓
SDDrug therapeutic incompatibility ✓ · ✓
SDDyspnoea · · ✓
SDGallbladder operation · · ✓
SDHeart rate increased · · ✓
SDMedical counselling · · ✓
SDPre-existing disease ✓ ✓ ✓
SDTachycardia · · ✓
SDVertigo ✓ ✓ ✓
SROAbdominal discomfort ✓ ✓ ✓
SROAbdominal pain ✓ ✓ ✓
SROChest discomfort ✓ ✓ ✓
SROEmergency care ✓ ✓ ✓
SROFeeling hot · · ✓
SROHot flush · · ✓
SROMusculoskeletal chest pain ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release